The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial.
Sign Up to like & getrecommendations! Published in 2017 at "American heart journal"
DOI: 10.1016/j.ahj.2017.03.007
Abstract: BACKGROUND Oral anticoagulants (OACs) reduce stroke risks with nonvalvular atrial fibrillation (AF); however, they are underused because of absolute or relative contraindications due to real or perceived risk of bleeding. Although left atrial appendage closure… read more here.
Keywords: device patients; trial; study; assessment watchman ... See more keywords